MGO One Seven LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,124 shares of the medical equipment provider’s stock after selling 102 shares during the quarter. MGO One Seven LLC’s holdings in Intuitive Surgical were worth $2,153,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the 4th quarter valued at $28,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently weighed in on ISRG. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Royal Bank of Canada decreased their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday. Truist Financial dropped their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research note on Wednesday. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $598.95.
Intuitive Surgical Stock Up 4.1 %
NASDAQ:ISRG opened at $508.13 on Friday. The company’s 50 day moving average is $513.65 and its 200-day moving average is $532.19. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The firm has a market cap of $180.99 billion, a price-to-earnings ratio of 79.27, a P/E/G ratio of 5.85 and a beta of 1.55.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm posted $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Buying and Selling
In other news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- How to Calculate Stock Profit
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- Investing in Construction Stocks
- Why Smart Investors Don’t Panic in Election Season
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.